Firmavis
/
SearchPricingData CoverageAboutRoadmap
/
SearchPricingData CoverageAboutRoadmap
Firmavis

The B2B company database built for Europe.

Company data on 8.7M+ businesses across 12 European markets — contacts, industry codes and, where available, financial figures, ready to search and export.

Product

  • Search
  • Pricing
  • Data Coverage
  • Data methodology
  • FAQ
  • Roadmap

Company

  • About
  • Contact

Legal

  • Privacy
  • Terms
  • Refunds
  • Cookies
  • Sub-processors
  • SCC Appendix
  • Remove your data
© 2026 Firmavis

MB Firmavis · Company code 307941710 · VAT LT100020426112 · Laisvės al. 85E-5, LT-44297 Kaunas, Lithuania · [email protected]

PL"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Reg. code0000092404
VATPL5271113612
  • Overview
  • Contacts
  • Financials
  • Description
  • Similar
  1. Home
  2. PLPoland
  3. "NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

PLWarszawa, Mazowieckie, Poland

  • Top 10% of its industry by revenue
  • Revenue up 3 years in a row
  • Profitable
  • 24 years in business
Registration code
0000092404
VAT number
PL5271113612
Address

UL. KRAKOWIAKÓW 4602-255 WARSZAWAPoland

Company details

Industry
Research and experimental development on natural sciences and engineering
NACE code
72.10
Legal form
Limited liability company (Sp. z o.o.)
Founded
2002 · 24 yr
Employees
Not on record
Revenue
€96.1M
Website
novonordisk.pl

Contact information

Financial data

FY 2024

Source: National business registers

About the company

"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ is a Limited liability company (Sp. z o.o.) registered under code 0000092404. Its registered office is located in , Poland. It operates within the Research and experimental development on natural sciences and engineering sector, which sits within the broader category.

For 2024, "NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported revenue of €96.1 million, indicative of a sizeable commercial operation. Revenue at "NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ has increased in each of the last 3 reported years, a growth pattern extending back to at least 2021. Financial results indicate a profitable performance in the reporting year.

Company facts and financials compiled from official company registers and publicly available business information, standardised and de-duplicated per country. Data last updated October 1, 2026.

Explore related

Similar companies

Same industry
1 found
Email
Likely valid

Is this your company?

Revenue2024 · YoY
€96,148,34533.5%Up 33.5% on the previous year
Net income2024
€11,001,272
Warszawa
Professional, scientific and technical activities
About our data
How we build our data
Professional Services in Poland
Companies in Warszawa
Data coverage in Poland
See all in Professional Services
INSTYTUT FIZJOLOGII I PATOLOGII SŁUCHUPLWarszawa€86.3M
INSTYTUT GRUŹLICY I CHORÓB PŁUCPLWarszawa€98.4M
NARODOWY INSTYTUT ONKOLOGII IM. MARII SKŁODOWSKIEJ-CURIE - PAŃSTWOWY INSTYTUT BADAWCZYPLWarszawa€671.2M
INSTYTUT HEMATOLOGII I TRANSFUZJOLOGIIPLWarszawa€105.8M
INSTYTUT PSYCHIATRII I NEUROLOGIIPLWarszawa€74.6M
PAREXEL POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄPLWarszawa€41.2M